Nivolumab Clearance Is Stationary in Resected Melanoma...

  • Main
  • 2019 / 05
  • Nivolumab Clearance Is Stationary in Resected Melanoma...

Nivolumab Clearance Is Stationary in Resected Melanoma Patients on Adjuvant Therapy: Implications of Disease Status on Time‐Varying Clearance

Hamuro, Lora, Statkevich, Paul, Bello, Akintunde, Roy, Amit, Bajaj, Gaurav
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1002/cpt.1502
Date:
May, 2019
File:
PDF, 571 KB
2019
Conversion to is in progress
Conversion to is failed